title: Etanercept is effective in patients with rheumatoid arthritis with no response to infliximab therapy.
authors.forename: J A
authors.initials: JA
authors.lastname: Gómez-Puerta
authors.forename: R
authors.initials: R
authors.lastname: Sanmartí
authors.forename: J R
authors.initials: JR
authors.lastname: Rodríguez-Cros
authors.forename: J D
authors.initials: JD
authors.lastname: Cañete
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D000069285:Infliximab; D008297:Male; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D000068800:Etanercept